Chesapeake Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.61M | Sell |
14,357
-854
| -6% | -$184K | 1.01% | 26 |
|
|
2026
Q1 | $3.31M | Buy |
15,211
+176
| +1% | +$39K | 1.02% | 26 |
|
|
2025
Q4 | $3.44M | Buy |
15,035
+317
| +2% | +$72.2K | 1.02% | 27 |
|
|
2025
Q3 | $3.41M | Buy |
14,718
+305
| +2% | +$62.1K | 1.04% | 26 |
|
|
2025
Q2 | $2.68M | Buy |
14,413
+680
| +5% | +$126K | 0.89% | 34 |
|
|
2025
Q1 | $2.88M | Sell |
13,733
-424
| -3% | -$82.4K | 1.03% | 28 |
|
|
2024
Q4 | $2.52M | Sell |
14,157
-365
| -3% | -$67.1K | 0.86% | 36 |
|
|
2024
Q3 | $2.87M | Sell |
14,522
-60
| -0.4% | -$11.2K | 0.98% | 33 |
|
|
2024
Q2 | $2.5M | Sell |
14,582
-227
| -2% | -$37.6K | 0.91% | 37 |
|
|
2024
Q1 | $2.7M | Sell |
14,809
-151
| -1% | -$26K | 0.98% | 33 |
|
|
2023
Q4 | $2.32M | Sell |
14,960
-163
| -1% | -$23.8K | 0.9% | 36 |
|
|
2023
Q3 | $2.25M | Sell |
15,123
-174
| -1% | -$25.5K | 0.94% | 34 |
|
|
2023
Q2 | $2.06M | Buy |
15,297
+915
| +6% | +$134K | 0.81% | 39 |
|
|
2023
Q1 | $2.29M | Buy |
14,382
+1,299
| +10% | +$199K | 0.96% | 32 |
|
|
2022
Q4 | $2.11M | Buy |
13,083
+2,305
| +21% | +$353K | 0.93% | 31 |
|
|
2022
Q3 | $1.45M | Buy |
10,778
+115
| +1% | +$16.5K | 0.66% | 47 |
|
|
2022
Q2 | $1.63M | Sell |
10,663
-122
| -1% | -$18.6K | 0.7% | 40 |
|
|
2022
Q1 | $1.75M | Sell |
10,785
-590
| -5% | -$85.7K | 0.64% | 41 |
|
|
2021
Q4 | $1.54M | Sell |
11,375
-277
| -2% | -$32.7K | 0.52% | 52 |
|
|
2021
Q3 | $1.26M | Sell |
11,652
-643
| -5% | -$73.5K | 0.45% | 57 |
|
|
2021
Q2 | $1.39M | Sell |
12,295
-777
| -6% | -$87.5K | 0.45% | 57 |
|
|
2021
Q1 | $1.41M | Sell |
13,072
-340
| -3% | -$36.4K | 0.47% | 55 |
|
|
2020
Q4 | $1.44M | Sell |
13,412
-467
| -3% | -$44.9K | 0.49% | 55 |
|
|
2020
Q3 | $1.22M | Buy |
13,879
+16
| +0.1% | +$1.51K | 0.45% | 66 |
|
|
2020
Q2 | $1.36M | Buy |
13,863
+603
| +5% | +$53.1K | 0.54% | 50 |
|
|
2020
Q1 | $1.01M | Sell |
13,260
-35
| -0.3% | -$2.98K | 0.47% | 65 |
|
|
2019
Q4 | $1.18M | Sell |
13,295
-473
| -3% | -$39.3K | 0.45% | 68 |
|
|
2019
Q3 | $1.04M | Sell |
13,768
-790
| -5% | -$54.2K | 0.43% | 76 |
|
|
2019
Q2 | $1.06M | Sell |
14,558
-1,269
| -8% | -$99.7K | 0.44% | 73 |
|
|
2019
Q1 | $1.27M | Sell |
15,827
-100
| -0.6% | -$8.18K | 0.56% | 48 |
|
|
2018
Q4 | $1.47M | Sell |
15,927
-920
| -5% | -$80.9K | 0.73% | 34 |
|
|
2018
Q3 | $1.59M | Sell |
16,847
-155
| -0.9% | -$14.7K | 0.71% | 37 |
|
|
2018
Q2 | $1.57M | Sell |
17,002
-874
| -5% | -$85.4K | 0.73% | 34 |
|
|
2018
Q1 | $1.69M | Buy |
+17,876
| New | +$1.96M | 0.78% | 33 |
|
Other funds holding ABBV
Chesapeake Wealth Management's ABBV Position: Q2 2026 in Review
Chesapeake Wealth Management reduced its AbbVie (ABBV) stake by 5.6% in Q2 2026, selling an estimated $184K and leaving 14,357 shares worth $3.61M. The position accounts for 1.01% of the portfolio, ranked #26.
Chesapeake Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 34 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Chesapeake Wealth Management held 14,357 shares of AbbVie worth $3.61M as of Q2 2026.
- Chesapeake Wealth Management sold 854 AbbVie shares in Q2 2026, an estimated $184K.
- AbbVie made up 1.01% of Chesapeake Wealth Management's portfolio in Q2 2026, its #26 holding.
- Chesapeake Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 34 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Chesapeake Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.